Hand Eczema Clinical Trial
Official title:
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1 (TRuE-CHE1): A Phase 3, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity (Investigator's Global Assessement (IGA) of CHE score 3 or 4).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00576550 -
A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema
|
Phase 4 | |
Completed |
NCT00404196 -
LEO19123 Cream in the Treatment of Hand Eczema
|
Phase 2 | |
Completed |
NCT05763914 -
A 24-week Single-blind Trial of Prevention of Hand Eczema in Cleaners
|
N/A | |
Recruiting |
NCT03026946 -
Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema
|
Phase 3 | |
Recruiting |
NCT03026907 -
Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema
|
Phase 3 | |
Completed |
NCT00488241 -
Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema
|
Phase 4 | |
Active, not recruiting |
NCT05906628 -
Topical Ruxolitinib Evaluation in Chronic Hand Eczema
|
Phase 2 | |
Terminated |
NCT01826630 -
A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema
|
N/A | |
Recruiting |
NCT04449575 -
Hand Eczema in the Health Care Sector
|
||
Completed |
NCT01591785 -
Treatment of Staphylococcus Aureus Colonization in Hand Eczema
|
N/A | |
Completed |
NCT00826592 -
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
|
N/A | |
Completed |
NCT02664805 -
Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema
|
Phase 2 | |
Completed |
NCT05471934 -
Satisfaction Survey - Cicaplast Mains
|
||
Active, not recruiting |
NCT04512339 -
Dupilumab in Severe Chronic Hand Eczema
|
Phase 2 | |
Completed |
NCT04375410 -
Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic
|